Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208295703> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W3208295703 endingPage "227" @default.
- W3208295703 startingPage "227" @default.
- W3208295703 abstract "Background: Covid-19 patients at end of life (EoL) suffer predominantly from rapidly escalating dyspnoea and agitation. An unusual symptom of Covid-19 is isolated extreme overwhelming cerebral agitation and Helms et al,1 report an observational series of 58 patients admitted to Intensive Care Unit with associated encephalopathy, prominent agitation and confusion. Case presentation: Male 74 year old patient with end-stage leukaemia, admitted to hospital with mild flu like symptoms. Tested positive Covid- 19.Hospitalised for two weeks, then discharged to a Nursing Home. Only symptom remained was insomnia, however this was impacting with increasing irritability in a previously calm man. The irritability escalated to extreme agitation, screaming out in deep distress. No headache or signs of meningism. Patient hospitalised, Palliative Medical phone advice requested. The agitation was not associated with dyspnoea, chest secretions or pain. Management & outcomes: A continuous sub-cutaneous infusion (CSCI) was commenced with opioid and midazolam and symptoms did not settle with increasing doses. The patient's close relative was an Oncology Nurse Specialist and was the only visitor allowed on ward. The patient's extreme agitation was deeply distressing and on day 3 phenobarbitone was commenced and within hours the patient settled and slept for the first time in three weeks. Phenobarbitone was delivered via stat dose and CSCI. The following day the patient required a third CSCI with diclofenac for resistant hyperpyrexia not controlled on regular paracetamol. The patient remained comfortable and passed away a few days later. Discussion: This isolated symptom appeared to present with extremely poor sleep for weeks, then escalating into extreme overwhelming agitation. At EoL this isolated symptom is an indication for use of Phenobarbitone, that renders sustained benefit. Conclusion: For 'patients with reversibility' it may indicate earlier than usual need for ventilation." @default.
- W3208295703 created "2021-11-08" @default.
- W3208295703 creator A5002872323 @default.
- W3208295703 creator A5011570418 @default.
- W3208295703 creator A5023569425 @default.
- W3208295703 creator A5043898396 @default.
- W3208295703 creator A5051759244 @default.
- W3208295703 creator A5057939279 @default.
- W3208295703 creator A5083528580 @default.
- W3208295703 date "2021-01-01" @default.
- W3208295703 modified "2023-09-26" @default.
- W3208295703 title "A case of COVID-19 presenting with insomnia, progressing to extreme agitation at end of life" @default.
- W3208295703 hasPublicationYear "2021" @default.
- W3208295703 type Work @default.
- W3208295703 sameAs 3208295703 @default.
- W3208295703 citedByCount "1" @default.
- W3208295703 countsByYear W32082957032021 @default.
- W3208295703 crossrefType "journal-article" @default.
- W3208295703 hasAuthorship W3208295703A5002872323 @default.
- W3208295703 hasAuthorship W3208295703A5011570418 @default.
- W3208295703 hasAuthorship W3208295703A5023569425 @default.
- W3208295703 hasAuthorship W3208295703A5043898396 @default.
- W3208295703 hasAuthorship W3208295703A5051759244 @default.
- W3208295703 hasAuthorship W3208295703A5057939279 @default.
- W3208295703 hasAuthorship W3208295703A5083528580 @default.
- W3208295703 hasBestOaLocation W32082957031 @default.
- W3208295703 hasConcept C118552586 @default.
- W3208295703 hasConcept C139265228 @default.
- W3208295703 hasConcept C141983124 @default.
- W3208295703 hasConcept C159110408 @default.
- W3208295703 hasConcept C177713679 @default.
- W3208295703 hasConcept C187212893 @default.
- W3208295703 hasConcept C2776153860 @default.
- W3208295703 hasConcept C2776376669 @default.
- W3208295703 hasConcept C2776814716 @default.
- W3208295703 hasConcept C2778000748 @default.
- W3208295703 hasConcept C2779753318 @default.
- W3208295703 hasConcept C2780820931 @default.
- W3208295703 hasConcept C2994186709 @default.
- W3208295703 hasConcept C42219234 @default.
- W3208295703 hasConcept C558461103 @default.
- W3208295703 hasConcept C70410870 @default.
- W3208295703 hasConcept C71924100 @default.
- W3208295703 hasConceptScore W3208295703C118552586 @default.
- W3208295703 hasConceptScore W3208295703C139265228 @default.
- W3208295703 hasConceptScore W3208295703C141983124 @default.
- W3208295703 hasConceptScore W3208295703C159110408 @default.
- W3208295703 hasConceptScore W3208295703C177713679 @default.
- W3208295703 hasConceptScore W3208295703C187212893 @default.
- W3208295703 hasConceptScore W3208295703C2776153860 @default.
- W3208295703 hasConceptScore W3208295703C2776376669 @default.
- W3208295703 hasConceptScore W3208295703C2776814716 @default.
- W3208295703 hasConceptScore W3208295703C2778000748 @default.
- W3208295703 hasConceptScore W3208295703C2779753318 @default.
- W3208295703 hasConceptScore W3208295703C2780820931 @default.
- W3208295703 hasConceptScore W3208295703C2994186709 @default.
- W3208295703 hasConceptScore W3208295703C42219234 @default.
- W3208295703 hasConceptScore W3208295703C558461103 @default.
- W3208295703 hasConceptScore W3208295703C70410870 @default.
- W3208295703 hasConceptScore W3208295703C71924100 @default.
- W3208295703 hasLocation W32082957031 @default.
- W3208295703 hasOpenAccess W3208295703 @default.
- W3208295703 hasPrimaryLocation W32082957031 @default.
- W3208295703 hasVolume "35" @default.
- W3208295703 isParatext "false" @default.
- W3208295703 isRetracted "false" @default.
- W3208295703 magId "3208295703" @default.
- W3208295703 workType "article" @default.